Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10570120 Neprilysin inhibitors

Patent 10570120 was granted and assigned to Theravance on February, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Theravance

Current Assignee

Theravance

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

105701200

Patent Inventor Names

Adam D. Hughes0

Melissa Fleury0

Date of Patent

February 25, 2020

Patent Application Number

162091120

Date Filed

December 4, 2018

Patent Citations

‌

US Patent 10189823 Neprilysin inhibitors

Patent Citations Received

‌

US Patent 11919888 Neprilysin inhibitors

‌

US Patent 11634413 Neprilysin inhibitors

Patent Primary Examiner

‌

Kamal A Saeed

Patent abstract

In one aspect, the invention relates to compounds having the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10570120 Neprilysin inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API